Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability

Ying-Tang Huang1, Lung-Ta Lee, Ping-Ping H Lee

  • 1Department of Marine Biotechnology, National Kaohsiung Marine University, Kaohsiung, Taiwan.

Anticancer Research
|September 15, 2005
PubMed

Insights

Focal adhesion kinase (FAK) is crucial for tumor cell migration and invasiveness. Inhibiting FAK with specific siRNA or flavonoids like luteolin and quercetin significantly reduces cancer cell movement.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Focal adhesion kinase (FAK) is a protein tyrosine kinase implicated in cancer progression.
  • Elevated FAK activity correlates with increased invasive potential in human carcinoma cells.

Purpose of the Study:

  • To investigate the role of FAK in regulating tumor cell migration.
  • To test the hypothesis that FAK is a key determinant of cancer cell invasiveness.

Main Methods:

  • Examined FAK function using flavonoid inhibitors (luteolin, quercetin) in MiaPaCa-2 cells.
  • Suppressed FAK expression using FAK-specific small-interfering RNAs (siRNA) in MiaPaCa-2 cells.

Main Results:

  • Flavonoid treatment and FAK siRNA reduced FAK phosphorylation and protein expression.
  • FAK suppression significantly inhibited MiaPaCa-2 cell migration without affecting proliferation or apoptosis.
  • FAK was identified as a key regulator of cell migration.

Conclusions:

  • FAK plays a critical role in regulating tumor cell migration and invasiveness.
  • FAK activity can be effectively suppressed by FAK siRNA, luteolin, and quercetin.
  • Targeting FAK presents a potential strategy for reducing tumor cell invasiveness.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...